Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Theodent secures FDA 510(k) clearance for Rennou® Varnish, the first professional fluoride-free cavity varnish authorized in the U.S.


News provided by

Theodent®

Jun 16, 2025, 06:00 ET

Share this article

Share toX

Share this article

Share toX

The Theodent Professional logo in copper-gold. It shows a circular cacao pod crest to the left of the words 'Theodent' and 'PROFESSIONAL'.
The Theodent Professional logo in copper-gold. It shows a circular cacao pod crest to the left of the words 'Theodent' and 'PROFESSIONAL'.

Addressing growing patient and provider concerns over fluoride, Theodent introduces Rennou® Varnish, the first professional cavity varnish to gain FDA 510(k) clearance for its fluoride-free formula. This groundbreaking product uses a patented, cacao-derived technology to offer an effective, and safe alternative for dentinal hypersensitivity. Rennou® Varnish is a prescription-only product.

NEW ORLEANS, June 16, 2025 /PRNewswire-PRWeb/ -- Theodent®, the science-driven oral-care company behind patented Rennou® technology, today announced the U.S. Food & Drug Administration has granted 510(k) clearance (K243777) for Rennou® Varnish, making it the first fluoride-free cavity varnish authorized for professional use in the United States.

The Class II clearance under 21 CFR 872.3260 (product code LBH) affirms that Rennou® Varnish is substantially equivalent to existing fluoride varnishes in safety and effectiveness while leveraging proprietary cacao-derived Rennou® technology instead of fluoride.

"For dentists seeking safe and effective alternatives to fluoride, the search is over."

Post this

"FDA clearance for Rennou® Varnish marks a pivotal advance in dentistry, giving clinicians a proven fluoride-free alternative to high-dose fluoride varnishes," said Joseph Fuselier, Co-CEO of Theodent®. "The varnish is only the beginning. Our award-winning Theodent® toothpaste already delivers Rennou® at home, and now we're expanding into a full professional line so every product—from chairside to bathroom sink—can strengthen smiles without fluoride."

"Our team demonstrated that Rennou® occludes dentinal tubules, delivering the same clinical benefits practitioners expect from cavity varnish, but without the high doses of fluoride," added Tetsuo Nakamoto, Ph.D., D.D.S., Co-CEO and Chief Scientific Officer.

"While I will likely keep some traditional 5% fluoride varnish on hand for those who request it, I intend to use Theodent's Rennou® Varnish as my primary post-prophylaxis treatment once it's released," said Kristi Soileau, DDS, MEd, MSHCE. "Although many dentists still support public fluoridation, patients locally and nationally remain concerned about cumulative fluoride exposure. The FDA's confirmation of Rennou's efficacy and safety gives me a strong reason to switch."

"For dentists seeking safe and effective alternatives to fluoride, the search is over. Patient interest in non-fluoride options is rising, driven by recent data on dose-related neurotoxicity," said Margaret Scarlett, D.M.D., Former National Fluoridation Lead Officer, CDC, and Former Senior Policy Analyst, U.S. Department of Health & Human Services. "This new Rennou® varnish is a safe, highly effective solution applied just like a traditional varnish, allowing dentists to confidently provide a safer option for families concerned about their children's total fluoride burden."

Key Highlights

  • FDA 510(k) Cleared (K243777): Regulatory validation as a Class II cavity varnish for dentinal hypersensitivity
  • Fluoride-Free Formula: Patented Rennou® technology combines theobromine, calcium, and phosphate
  • Familiar Workflow: 3 % resin matrix, rapid set time, and unit-dose packaging mirror standard varnish application
  • Prescription-Only: Ensures professional application and oversight
  • Patient-Friendly Flavors: Spearmint, Strawberry, Cherry, Bubble Gum
  • Made in the USA: Manufactured in an FDA-registered, ISO-13485 facility

Availability

Rennou® Varnish will launch to U.S. dental professionals in Q4 2025. Theodent® is finalizing distribution partnerships, with further details forthcoming. International launches will follow pending local regulatory approvals.

For more information regarding Rennou® Varnish, please visit www.theodentpro.com.

About Theodent®

Founded in New Orleans, Theodent® (a subsidiary of Theocorp Holding Company) leverages proprietary Rennou® technology to create safe, effective oral-care products without fluoride. The company's portfolio includes award-winning fluoride-free toothpastes, professional-strength formulations, and now the first FDA-cleared fluoride-free dental varnish. Learn more at www.theodent.com.

Media Contact

Communications Manager, Theodent®, 1 5042645050, [email protected], theodentpro.com 

SOURCE Theodent®

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.